Pre-market · Oct 8, 9:00 am ET · After hours $1.76 0.00%
Open$1.73
Prev close$1.75
Day range$1.71 – $1.77
Volume1.10M
Market cap$783.12M
P/E (TTM)–
Dividend yield–
LXRX Stock News
Headlines matching Lexicon Pharmaceuticals or the LXRX ticker, most recent first.
Cantor Fitzgerald Initiates Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Announces Target Price $8Market news · 28 Sep 2026 · Direct mention
Citi Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $3.1Market news · 11 Sep 2026 · Direct mention
Piper Sandler Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $6Market news · 7 Aug 2026 · Direct mention
Earnings Flash (LXRX) Lexicon Pharmaceuticals Posts Q2 Loss $0.07 a Share, Vs. FactSet Est of $0.05 LossNegativeMT Newswires · 6 Aug 2026 · Direct mention
H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $6Market news · 24 Aug 2026 · Direct mention
Citi Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Raises Target Price to $3.1PositiveMarket news · 11 May 2026 · Direct mention
Analysts Offer Insights on Healthcare Companies: ProQR (PRQR), Lexicon Pharmaceuticals (LXRX) and Carlsmed, Inc. (CARL)TipRanks · 15 Apr 2026 · Direct mention
H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Raises Target Price to $6PositiveMarket news · 6 Mar 2026 · Direct mention
Citi Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Raises Target Price to $2.3PositiveMarket news · 10 Mar 2026 · Direct mention
H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $4Market news · 22 Jan 2026 · Direct mention
Citi Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Raises Target Price to $1.9PositiveMarket news · 7 Aug 2025 · Direct mention
Piper Sandler Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Cuts Target Price to $6NegativeMarket news · 15 May 2025 · Direct mention
Needham Maintains Lexicon Pharmaceuticals(LXRX.US) With Hold RatingMarket news · 7 Mar 2025 · Direct mention
Leerink Partners Downgrades Lexicon Pharmaceuticals(LXRX.US) to Hold Rating, Announces Target Price $1NegativeMarket news · 5 Mar 2025 · Direct mention
Leerink Partners Maintains Lexicon Pharmaceuticals(LXRX.US) With Hold Rating, Maintains Target Price $1Market news · 11 Mar 2025 · Direct mention
Discussion
No comments yet — be the first to weigh in on LXRX.
No comments yet — be the first to weigh in on LXRX.